Wigginton Jon Marc 4
4 · MACROGENICS INC · Filed Feb 25, 2019
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Wigginton Jon Marc
Senior VP, Clinical Dev.
Transactions
- Award
Employee stock option (right to buy)
2019-02-21+90,000→ 90,000 totalExercise: $21.88Exp: 2029-02-21→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.